287
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Trial-based cost-effectiveness of abatacept for rheumatoid arthritis patients in Italy

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maurizio Benucci, Maria Infantino & Mariangela Manfredi. (2020) Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage. Journal of Medical Economics 23:9, pages 923-925.
Read now
Maurizio Benucci, Arianna Damiani, Mariangela Manfredi, Maria Infantino, Valentina Grossi & Francesca Li Gobbi. (2019) Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life. ClinicoEconomics and Outcomes Research 11, pages 405-409.
Read now

Articles from other publishers (4)

Alisson Pugliesi, Amanda Borges de Oliveira, Ana Beatrice Oliveira, Ricardo Xavier, Licia Maria Henrique da Mota, Manoel Barros Bertolo, Miguel Angel Gonzalez-Gay, Gustavo Citera & Luiz Sergio Fernandes de Carvalho. (2023) Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis. Advances in Rheumatology 63:1.
Crossref
Andrea Marcellusi, Chiara Bini, Ketty Peris, Paolo Antonio Ascierto & Francesco Saverio Mennini. (2020) ost of illness del carcinoma cutaneo a cellule squamose (CSCC). Global & Regional Health Technology Assessment 7:1, pages 148-153.
Crossref
Hannah A. Blair & Emma D. Deeks. (2017) Abatacept: A Review in Rheumatoid Arthritis. Drugs 77:11, pages 1221-1233.
Crossref
Francesco Saverio Mennini, Andrea Marcellusi, Lara Gitto & Florenzo Iannone. (2017) Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients. Clinical Drug Investigation 37:4, pages 375-386.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.